Cerebrofaciothoracic Dysplasia

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Drugs and Important Biological Agents (IBA) related to Cerebrofaciothoracic Dysplasia:

1.	Growth Hormone (Somatotropin)IBA 09/01/2006 - "Two years of growth hormone treatment in the first growth hormone deficient patient with cerebrofaciothoracic dysplasia."
2.	zinc-binding protein (zinc binding protein)IBA 01/01/2022 - "We further linked the putative zinc transporter SLC30A9 to mitochondrial ribosomes and OxPhos integrity and established RAB5IF as the second gene harbouring pathogenic variants that cause cerebrofaciothoracic dysplasia. "